1Yi, Y., Philips, Z., Bergman, G. & Burslem, K. Economic models in type 2 diabetes. Curr Med Res Opin, 2010.13.
2Levy, J. C., Cull, C. A., Stratton, I. M., Holman, R. R. & Turner, R. C. The UKPDS study on glycemic control and arterial hypertension in type II diabetes: objectives, structure and preliminary results. Journ An- nu Diabetol Hotel Dieu, 1993.123-137 .
3Clarke, P. M. et al. A model to estimate the lifetime health outcomes of patients with Type 2 dia- betes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetolo- gia47, 2004.1747-1759.
6Rogers J A, Polhamus D, Gillespie W R, et al. Combining patient-level and summary-level data for Alzheimer's disease modeling and simulation: a beta regression meta-analysis [J]. J Pharmacokinet Pharma- eodyn,2012,39(5) :479-498.
3DRUMMOND M F, SCULPHER M J, TORRANCE G W, et al.卫生保健项目经济学评估方法[M].李士雪译.北京:人民卫生出版社,2008.
4Weinstein MC, Torrance G, McGuire A.QALYs:The Basics[J]. Value in Health,2009,12(Suppl1):5-9.
5Kind P, Lafata JE, Matuszewski K, et al. The Use of QALYs in Clinical and Patient Decision-Making:Issues and Prospects [J].Value in Health,2009,12(Suppl 1):27-30.
6Airoldi M, Morton A. Adjusting Life for Quality or Disability: Stylistic Difference or Substantial Dispute? [J].Health Economics,2009,18 ( 11 ): 1237-1247.
